Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly Japanese, and Healthy Younger Adult Japanese Subjects
Clinical trial NCT02857777 · COMPLETED
Trial details
- NCT number
- NCT02857777
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-09
- Primary completion
- 2017-01-27
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.